IP Library Granted Patent US 7,396,661
Granted Patent B2
US 7,396,661 · App. 10/367,169 · Granted Jul 8, 2008

Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,396,661
App. No.
10/367,169
Granted
Jul 8, 2008
Kind
B2
Abstract

The present invention generally relates to methods and compositions for expressing proteins or polypeptides in prokaryotic hosts using eukaryotic signal sequences.

Claims (12)

1. A method of preparing a polypeptide display library, which method comprises the steps of introducing a polynucleotide encoding an exogenous polypeptide into the genome of a replicable genetic package to form a fusion protein with an endogenous protein that is normally expressed from the outersurface of the replicable genetic package, wherein the polynucleotide is operably linked to a eukaryotic signal sequence which encodes a signal peptide MKILILGIFLFLCSTPAWA (SEQ ID NO: 1), and expressing said fusion protein, wherein the replicable genetic package is a bacteriophage or phagemid.

2. A method according to claim 1 , wherein the polypeptide is a eukaryotic polypeptide.

3. A method according to claim 1 , wherein the polypeptide is a prokaryotic polypeptide.

4. A method according to claim 1 , wherein the polypeptide is an antibody.

5. A method according to claim 1 , wherein the polypeptide is an antibody that is a mouse antibody, a human antibody, or a chimeric antibody.

6. A method according to claim 1 , wherein the polypeptide is a whole antibody or binding fragment thereof.

7. A method according to claim 1 , wherein the polypeptide is an antibody binding fragment that is a single chain fragment, an Fv fragment or a Fab fragment.

8. A method according to claim 1 , wherein the signal sequence is 5′ to the polynucleotide sequence encoding the polypeptide.

9. A method according to claim 1 , wherein the signal sequence and the polypeptide are separated by zero amino acids.

10. A method according to claim 1 , wherein the bacteriophage is a filamentous phage.

11. A method according to claim 1 , further comprising the steps of (a) screening, (b) enriching the polypeptide display library, and/or (c) subcloning the polynucleotide encoding the identified polypeptide into an expression vector.

12. A method according to claim 10 , wherein the filamentous phage is an M13, Fd, or F1 phage.

Assignments (2)
RELEASE OF SECURITY INTEREST Recorded Dec 23, 2025
From: SILICON VALLEY BANK
To: XOMA TECHNOLOGY LTD.
Reel/Frame 073790/0484 →
SECURITY INTEREST Recorded May 9, 2018
From: XOMA TECHNOLOGY LTD.
To: SILICON VALLEY BANK
Reel/Frame 046115/0459 →